In a rare anti-vimentin encephalitis case, molecular imaging detected abnormalities that declined alongside neurologic improvement following immunotherapy.
Review calls for senescence screening and EV proteomic profiling to assess whether cell therapy products can maintain protein homeostasis after transplantation